Log in

Relevant bibliographies by topics / Transforming growth factors / Journal articles

To see the other types of publications on this topic, follow the link: Transforming growth factors.

Journal articles on the topic 'Transforming growth factors'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Transforming growth factors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Hsuan, J. Justin. "Transforming growth factors β". British Medical Bulletin 45, № 2 (1989): 425–37. http://dx.doi.org/10.1093/oxfordjournals.bmb.a072332.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Massagué, Joan. "The transforming growth factors." Trends in Biochemical Sciences 10, no. 6 (1985): 237–40. http://dx.doi.org/10.1016/0968-0004(85)90141-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

HELDIN, Carl-Henrik, and Bengt WESTERMARK. "Growth factors as transforming proteins." European Journal of Biochemistry 184, no. 3 (1989): 487–96. http://dx.doi.org/10.1111/j.1432-1033.1989.tb15041.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Moses, Harold L., Jorma Keski-Oja, Robert J. Coffey, Russette M. Lyons, Nancy J. Sipes, and Charles C. Bascom. "Transforming growth factors and oncogenes." European Journal of Cancer and Clinical Oncology 23, no. 11 (1987): 1780. http://dx.doi.org/10.1016/0277-5379(87)90651-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lawrence, D. A. "Transforming growth factors-an overview." Biology of the Cell 53, no. 2 (1985): 93–98. http://dx.doi.org/10.1111/j.1768-322x.1985.tb00358.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Stenn, Kurt S., Raymond L. Barnhill, and Yasmin Johnston. "Transforming growth factors and histopathologic interpretation." Journal of the American Academy of Dermatology 17, no. 1 (1987): 161–63. http://dx.doi.org/10.1016/s0190-9622(87)70185-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Hammerman, M. R., S. A. Rogers, and G. Ryan. "Growth factors and metanephrogenesis." American Journal of Physiology-Renal Physiology 262, no. 4 (1992): F523—F532. http://dx.doi.org/10.1152/ajprenal.1992.262.4.f523.

Full text

Abstract:

The formation of all organs during embryogenesis, including kidney, is dependent on the timed and sequential expression of a number of polypeptide growth factors. Synthesis and actions of one or more members of the insulin-like growth factor, epidermal growth factor/transforming growth factor-alpha, transforming growth factor-beta, platelet-derived growth factor, fibroblast growth factor, and nerve growth factor families have been characterized in the developing metanephric kidney. Studies originating from a number of laboratories have defined the localization of growth factor mRNAs, receptors

APA, Harvard, Vancouver, ISO, and other styles

8

Keski-Oja, Jorma, Edward B. Leof, Russette M. Lyons, Robert J. Coffey, and Harold L. Moses. "Transforming growth factors and control of neoplastic cell growth." Journal of Cellular Biochemistry 33, no. 2 (1987): 95–107. http://dx.doi.org/10.1002/jcb.240330204.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Archer, J. R. "Ankylosing spondylitis, IgA, and transforming growth factors." Annals of the Rheumatic Diseases 54, no. 7 (1995): 544–46. http://dx.doi.org/10.1136/ard.54.7.544.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Gol-Winkler, R. "5 Paracrine action of transforming growth factors." Clinics in Endocrinology and Metabolism 15, no. 1 (1986): 99–115. http://dx.doi.org/10.1016/s0300-595x(86)80044-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Salomon, D. S., F. Ciardiello, E. Valverius, T. Saeki, and N. Kim. "Transforming growth factors in human breast cancer." Biomedicine & Pharmacotherapy 43, no. 9 (1989): 661–67. http://dx.doi.org/10.1016/0753-3322(89)90084-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

IHLE, J. N. "Transforming Genes: Oncogenes, Genes, and Growth Factors." Science 237, no. 4818 (1987): 1060–61. http://dx.doi.org/10.1126/science.237.4818.1060-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Neal, Harold J. "Crescentic glomerulonephritis: associations and transforming growth factors." Journal and proceedings of the Royal Society of New South Wales 136, no. 1-4 (2003): 51–52. http://dx.doi.org/10.5962/p.361514.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Mak, Robert H., and Wai W. Cheung. "Transforming growth factors and insulin-like growth factors in chronic kidney disease." Journal of Organ Dysfunction 5, no. 1 (2009): 59–64. http://dx.doi.org/10.1080/17471060701486225.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Centrella, Michael, Thomas L. McCarthy, and Ernesto Canalis. "Effects of Transforming Growth Factors on Bone Cells." Connective Tissue Research 20, no. 1-4 (1989): 267–75. http://dx.doi.org/10.3109/03008208909023896.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

MADRI, JOSEPH A., OLIVIER KOCHER, JUNE R. MERWIN, LEONARD BELL, ADELINE TUCKER, and CRAIG T. BASSON. "Interactions of Vascular Cells with Transforming Growth Factors-?" Annals of the New York Academy of Sciences 593, no. 1 Transforming (1990): 243–58. http://dx.doi.org/10.1111/j.1749-6632.1990.tb16116.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Rizzino, Angie, and Eric Ruff. "Parameters for optimizing detection of transforming growth factors." Journal of Tissue Culture Methods 10, no. 2 (1986): 109–15. http://dx.doi.org/10.1007/bf01404601.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Krieglstein, Kerstin, Matthias Rufer, Clemens Suter-Crazzolara та Klaus Unsicker. "Neural functions of the transforming growth factors β". International Journal of Developmental Neuroscience 13, № 3-4 (1995): 301–15. http://dx.doi.org/10.1016/0736-5748(94)00062-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Massagu�, Joan, Sela Cheifetz, Ronald A. Ignotz, and Frederick T. Boyd. "Multiple type-? transforming growth factors and their receptors." Journal of Cellular Physiology 133, S5 (1987): 43–47. http://dx.doi.org/10.1002/jcp.1041330409.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Jingushi, S., S. P. Scully, M. E. Joyce, Y. Sugioka, and M. E. Bolander. "Transforming growth factor-?1 and fibroblast growth factors in rat growth plate." Journal of Orthopaedic Research 13, no. 5 (1995): 761–68. http://dx.doi.org/10.1002/jor.1100130516.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Jankowski, J., R. McMenemin, D. Hopwood, J. Penston, and K. G. Wormsley. "Abnormal expression of growth regulatory factors in Barrett's oesophagus." Clinical Science 81, no. 5 (1991): 663–68. http://dx.doi.org/10.1042/cs0810663.

Full text

Abstract:

1. In order to assess potential abnormalities in the control of mucosal proliferation, 30 patients with Barrett's oesophagus were studied in order to evaluate the presence and distribution of epidermal growth factor, transforming growth factor-α and epidermal growth factor receptor to determine the Ki-67 labelling index in the affected oesophageal mucosa. Serial sections were analysed immunohistochemically. Ten of the patients had adenocarcinoma in the Barrett's mucosa and the other 20 had differing histological types of Barrett's mucosa (10, intestinal-type; 10, fundic-or cardiac-type). 2. Th

APA, Harvard, Vancouver, ISO, and other styles

22

Hemmings, Robert, Jean Langlais, Tommaso Falcone, Louis Granger, Pierre Miron та Harvey Guyda. "Human embryos produce transforming growth factors α activity and insulin-like growth factors II". Fertility and Sterility 58, № 1 (1992): 101–4. http://dx.doi.org/10.1016/s0015-0282(16)55144-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Haralson, Michael A. "Transforming growth factor-β, other growth factors, and the extracellular matrix". Journal of Laboratory and Clinical Medicine 130, № 5 (1997): 455–58. http://dx.doi.org/10.1016/s0022-2143(97)90120-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Massagué, J. "Transforming growth factor-alpha. A model for membrane-anchored growth factors." Journal of Biological Chemistry 265, no. 35 (1990): 21393–96. http://dx.doi.org/10.1016/s0021-9258(18)45745-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Dart, Linda L., Diane M. Smith, Chester A. Meyers, Michael B. Sporn, and Charles A. Frolik. "Transforming growth factors from a human tumor cell: characterization of transforming growth factor .beta. and identification of high molecular weight transforming growth factor .alpha." Biochemistry 24, no. 21 (1985): 5925–31. http://dx.doi.org/10.1021/bi00342a035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Massagué, J. "Transforming growth factor-beta modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-alpha." Journal of Cell Biology 100, no. 5 (1985): 1508–14. http://dx.doi.org/10.1083/jcb.100.5.1508.

Full text

Abstract:

The epidermal growth factor (EGF) receptor mediates the induction of a transformed phenotype in normal rat kidney (NRK) cells by transforming growth factors (TGFs). The ability of EGF and its analogue TGF-alpha to induce the transformed phenotype in NRK cells is greatly potentiated by TGF-beta, a polypeptide that does not interact directly with binding sites for EGF or TGF-alpha. Our evidence indicates that TGF-beta purified from retrovirally transformed rat embryo cells and human platelets induces a rapid (t 1/2 = 0.3 h) decrease in the binding of EGF and TGF-alpha to high-affinity cell surfa

APA, Harvard, Vancouver, ISO, and other styles

27

PITTELKOW, MARK R., ROBERT J. COFFEY, and HAROLD L. MOSES. "Keratinocytes Produce and Are Regulated by Transforming Growth Factors." Annals of the New York Academy of Sciences 548, no. 1 Endocrine, Me (1988): 211–24. http://dx.doi.org/10.1111/j.1749-6632.1988.tb18809.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

LYONS, Russette M., and Harold L. MOSES. "Transforming growth factors and the regulation of cell proliferation." European Journal of Biochemistry 187, no. 3 (1990): 467–73. http://dx.doi.org/10.1111/j.1432-1033.1990.tb15327.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Visser, Jenny A., та Axel P. N. Themmen. "Downstream factors in transforming growth factor-β family signaling". Molecular and Cellular Endocrinology 146, № 1-2 (1998): 7–17. http://dx.doi.org/10.1016/s0303-7207(98)00198-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Konttinen, Y. T., P. Kemppinen, T. F. Li, et al. "Transforming and epidermal growth factors in degenerated intervertebral discs." Journal of Bone and Joint Surgery. British volume 81-B, no. 6 (1999): 1058–63. http://dx.doi.org/10.1302/0301-620x.81b6.0811058.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Madri, Joseph A., Leonard Bell, and June Rae Merwin. "Modulation of vascular cell behavior by transforming growth factors ?" Molecular Reproduction and Development 32, no. 2 (1992): 121–26. http://dx.doi.org/10.1002/mrd.1080320207.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Bascom, Charles C., Nancy J. Sipes, Robert J. Coffey, and Harold L. Moses. "Regulation of epithelial cell proliferation by transforming growth factors." Journal of Cellular Biochemistry 39, no. 1 (1989): 25–32. http://dx.doi.org/10.1002/jcb.240390104.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Coffey, Robert J., Carol M. McCutchen, Ramona Graves-Deal, and William H. Polk. "Transforming growth factors and related peptides in gastrointestinal neoplasia." Journal of Cellular Biochemistry 50, S16G (1992): 111–18. http://dx.doi.org/10.1002/jcb.240501120.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Runser, S., and N. Cerletti. "Transforming growth factors beta: conformational stability and features of the denaturation of recombinant human transforming growth factors beta 2 and beta 3." Biotechnology and Applied Biochemistry 22, no. 1 (1995): 39–53. http://dx.doi.org/10.1111/j.1470-8744.1995.tb00342.x.

Full text

Abstract:

Transforming growth factors beta (TGF‐beta) are cytokines with multiple biological activities. Their development as biopharmaceutical drugs targets the control of complex physiological processes such as osteogenesis and epithelial cell differentiation. We report here the first characterization of the recombinant human (rh) TGF‐beta 2 and rhTGF‐beta 3 isoforms in terms of their conformational stability and structural transitions induced by a chaotrope or temperature. The transitions detected by CD spectroscopy suggested that thermal denaturation of both TGF‐beta isoforms apparently fitted a sim

APA, Harvard, Vancouver, ISO, and other styles

35

Tremollieres, Florence A., Donna D. Strong, David J. Baylink та Subburaman Mohan. "Insulin-like growth factor II and transforming growth factor β1 regulate insulin-like growth factor I secretion in mouse bone cells". Acta Endocrinologica 125, № 5 (1991): 538–46. http://dx.doi.org/10.1530/acta.0.1250538.

Full text

Abstract:

Abstract. Bone cells in culture produce and respond to growth factors, suggesting that local as well as systemic factors regulate bone volume. Previous studies have shown that IGF-I is the major mitogen produced by mouse bone cells and that its production is regulated by systemic agents such as PTH and estrogen. Because IGF-II and transforming growth factor β1 have been shown, respectively, to increase and decrease MC3T3-E1 cell proliferation, we tested the hypothesis that these two growth factors modulate the production of IGF-I in this cell line. In order to eliminate artifacts owing to IGF

APA, Harvard, Vancouver, ISO, and other styles

36

Peña-Ortiz, Miguel Ángel, Liliana Germán-Castelán, and Aliesha González-Arenas. "Growth factors and kinases in glioblastoma growth." Advances in Modern Oncology Research 2, no. 5 (2016): 248. http://dx.doi.org/10.18282/amor.v2.i5.100.

Full text

Abstract:

<p>Glioblastoma multiforme (GBM) is the most aggressive type of brain cancer, having the highest invasion, migration, proliferation, and angiogenesis rates. Several signaling pathways are involved in the regulation of these processes including growth factors and their tyrosine kinase receptors, such as vascular endothelial growth factor (VEGF), transforming growth factor beta (TGFβ), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), and insulin-like growth factor–I (IGF–I). Different kinases and regulators also participate in signaling pathways initiated by growth fa

APA, Harvard, Vancouver, ISO, and other styles

37

Keski-Oja, Jorma, Arnold E. Postlethwaite, and Harold L. Moses. "Transforming Growth Factors in the Regulation of Malignant Cell Growth and Invasion." Cancer Investigation 6, no. 6 (1988): 705–24. http://dx.doi.org/10.3109/07357908809078038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Wajeetongratana, Prateep. "Economic growth and its key factors: an alternative view on the factors stimulating agriculture growth." E3S Web of Conferences 175 (2020): 13028. http://dx.doi.org/10.1051/e3sconf/202017513028.

Full text

Abstract:

This research study makes an attempt to study the impacts of natural resources as well as financial and labor factors on economic development of contemporary states. Also, it investigates the correlation between all these factors mentioned above, in the context of countries’ economic growth. The obtained here results have helped us determine the core reasons behind international migration as a global phenomenon applicable to all countries without exceptions. Indirectly, we also demonstrate the transforming role of the labour factor as applied to economic development of countries and regions. F

APA, Harvard, Vancouver, ISO, and other styles

39

Metzler, Veronika Maria, Christian Pritz, Anna Riml, et al. "Separation of cell survival, growth, migration, and mesenchymal transdifferentiation effects of fibroblast secretome on tumor cells of head and neck squamous cell carcinoma." Tumor Biology 39, no. 11 (2017): 101042831770550. http://dx.doi.org/10.1177/1010428317705507.

Full text

Abstract:

Fibroblasts play a central role in tumor invasion, recurrence, and metastasis in head and neck squamous cell carcinoma. The aim of this study was to investigate the influence of tumor cell self-produced factors and paracrine fibroblast–secreted factors in comparison to indirect co-culture on cancer cell survival, growth, migration, and epithelial–mesenchymal transition using the cell lines SCC-25 and human gingival fibroblasts. Thereby, we particularly focused on the participation of the fibroblast-secreted transforming growth factor beta-1.Tumor cell self-produced factors were sufficient to e

APA, Harvard, Vancouver, ISO, and other styles

40

Bidey, SP, DJ Hill, and MC Eggo. "Growth factors and goitrogenesis." Journal of Endocrinology 160, no. 3 (1999): 321–32. http://dx.doi.org/10.1677/joe.0.1600321.

Full text

Abstract:

By combining data from studies of multinodular non-toxic goitre (MNTG) with data from rat models of goitre induction and in vitro models, a map of the growth factors involved in goitrogenesis has been constructed. We have addressed the roles of the insulin-like growth factors, transforming growth factors, fibroblast growth factors, endothelins, etc. We hypothesise that an imbalance in the interactions between the various growth factor axes exists in MNTG which favours cell replication. Thyrotrophin, although not significantly elevated in MNTG, exerts critical effects through interactions with

APA, Harvard, Vancouver, ISO, and other styles

41

Lee, G., L. R. Ellingsworth, S. Gillis, R. Wall, and P. W. Kincade. "Beta transforming growth factors are potential regulators of B lymphopoiesis." Journal of Experimental Medicine 166, no. 5 (1987): 1290–99. http://dx.doi.org/10.1084/jem.166.5.1290.

Full text

Abstract:

Members of the transforming growth factor beta (TGF-beta) family of polypeptides were found to be potent in vitro inhibitors of kappa light chain expression on normal bone marrow-derived and transformed cloned pre-B cells, and of the maturation of these cells to mitogen responsiveness. The inhibition by TGF-beta was selective in that Ia expression was not blocked. Together with the observations that LPS, IL-1, NZB serum factors, IL-4, and IFN-gamma preferentially induced either kappa or Ia, or both, on a pre-B cell line, these results further suggest that acquisition of Ig and class II molecul

APA, Harvard, Vancouver, ISO, and other styles

42

COMMISSIONG, JOHN W., TAKAO TAKESHIMA, JANE M. JOHNSTON, and KOTARO SHIMODA. "EFFECTS OF TRANSFORMING GROWTH FACTORS ON DOPAMINERGIC NEURONS IN CULTURE." Neurochemistry International 30, no. 4-5 (1997): 393–99. http://dx.doi.org/10.1016/s0197-0186(96)00074-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Hamburger, A. W., C. P. White, and F. E. Dunn. "Secretion of transforming growth factors by primary human tumour cells." British Journal of Cancer 51, no. 1 (1985): 9–14. http://dx.doi.org/10.1038/bjc.1985.2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Castilla, Alberto, Jesús Prieto та Nelson Fausto. "Transforming Growth Factors β1 and α in Chronic Liver Disease". New England Journal of Medicine 324, № 14 (1991): 933–40. http://dx.doi.org/10.1056/nejm199104043241401.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Chang, E. B. "Transforming growth factors and intestinal epithelia: More questions than answers." Gastroenterology 97, no. 6 (1989): 1587–88. http://dx.doi.org/10.1016/0016-5085(89)90408-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

van der Kruijssen, C. M. M., A. Feijen, D. Huylebroeck та A. J. M. van den Eijnden-van Raaij. "Modulation of Activin Expression by Type β Transforming Growth Factors". Experimental Cell Research 207, № 2 (1993): 407–12. http://dx.doi.org/10.1006/excr.1993.1208.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Leake, Robin. "Transforming growth factors alpha & beta — Positive and negative regulators of epithelial growth." European Journal of Cancer 33 (June 1997): S11. http://dx.doi.org/10.1016/s0959-8049(97)89359-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Ellis, James S., Daniel J. Paull, Sumit Dhingra, et al. "Growth Factors and Ocular Scarring." European Ophthalmic Review 03, no. 02 (2009): 58. http://dx.doi.org/10.17925/eor.2009.03.02.58.

Full text

Abstract:

Growth factors play a part in every stage of the wound healing process that leads to scar tissue formation. Ocular scarring can cause decreased vision or blindness by virtue of the opaque nature of the new matrix that is deposited as scar tissue (as in the lens or cornea). In addition, the contractile nature of the ocular scar tissue is the most common cause of failed retinal attachment. Scar formation after glaucoma surgery can lead to surgery failure. Growth factors, particularly the transforming growth factor (TGF-βs), play a major role in scar tissue formation in the eye and induce the syn

APA, Harvard, Vancouver, ISO, and other styles

49

McWilliam, R., R. E. Leake, and J. R. T. Coutts. "Growth Factors in Human Ovarian Follicle Fluid and Growth Factor Receptors in Granulosa-Luteal Cells." International Journal of Biological Markers 10, no. 4 (1995): 216–20. http://dx.doi.org/10.1177/172460089501000405.

Full text

Abstract:

The levels of oestradiol (E2), progesterone (P4), transforming growth factor a (TGFa), transforming growth factor β2 (TGFβ2), insulin-like growth factor I (IGF-I), platelet-derived growth factor AB (PDGF-AB) and epidermal growth factor (EGF) were measured in follicular fluids obtained from patients undergoing ovarian stimulation as part of an in vitro fertilisation program. Each of the substances was detected in all of the fluid samples tested, except TGFα (which was detected in 90% of samples tested), PDGF-AB (70%) and EGF (2%). Comparisons were made between each of these factors, follicular

APA, Harvard, Vancouver, ISO, and other styles

50

Rifkin, Daniel B., and Vesna Todorovic. "Bone matrix to growth factors: location, location, location." Journal of Cell Biology 190, no. 6 (2010): 949–51. http://dx.doi.org/10.1083/jcb.201008116.

Full text

Abstract:

The demonstration that fibrillin-1 mutations perturb transforming growth factor (TGF)–β bioavailability/signaling in Marfan syndrome (MFS) changed the view of the extracellular matrix as a passive structural support to a dynamic modulator of cell behavior. In this issue, Nistala et al. (2010. J. Cell Biol. doi: 10.1083/jcb.201003089) advance this concept by demonstrating how fibrillin-1 and -2 regulate TGF-β and bone morphogenetic protein (BMP) action during osteoblast maturation.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!